William Demers
Director of Finance/CFO en POINT Biopharma, Inc. (United States) .
Perfil
William Demers is currently the Chief Financial Officer at POINT Biopharma, Inc. in the United States.
Prior to this, he was the Chief Financial Officer at Contract Pharmaceuticals Ltd.
and AgMedica Bioscience, Inc. He also worked as a Senior Assurance Partner at Ernst & Young LLP from 2014 to 2018.
In terms of education, he received an undergraduate degree from Wilfrid Laurier University.
Additionally, he is currently serving as the Chief Financial Officer & Secretary at POINT Biopharma Global, Inc. from 2021 to 2023.
Cargos activos de William Demers
Empresas | Cargo | Inicio |
---|---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Director of Finance/CFO | 01/08/2020 |
Antiguos cargos conocidos de William Demers.
Empresas | Cargo | Fin |
---|---|---|
POIT BIOP | Director of Finance/CFO | 27/12/2023 |
AgMedica Bioscience, Inc.
AgMedica Bioscience, Inc. Agricultural Commodities/MillingProcess Industries Part of Atlas Global Brands, Inc., AgMedica Bioscience, Inc. is a Canadian company that cultivates, produces, distributes, and sells cannabis-related products. The private company is based in Chatham-Kent, Canada. AgMedica Bioscience was acquired by Silver Phoenix Resources, Inc. on January 04, 2023 for $9.32 million. The company was founded by Peter van Mol. Trevor Henry has been the CEO of the company since 2016. | Director of Finance/CFO | 01/08/2020 |
Contract Pharmaceuticals Ltd.
Contract Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Contract Pharmaceuticals Ltd. is a contract development and manufacturing organization (CDMO) specializing in non-sterile liquid and semi-solid pharmaceutical products. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Canadian company has over 25 years of experience in the industry and has built its expertise in liquids and semi-solids. The company's product development team consists of 45 people, including more than 30 scientists, with decades of formulation development and analytical experience. The company was founded in 1991, and Jan Sahai has been the CEO of the company since 2005. | Director of Finance/CFO | 01/07/2019 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/06/2018 |
Formación de William Demers.
Wilfrid Laurier University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
POIT BIOP | Health Technology |
Empresas privadas | 4 |
---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
AgMedica Bioscience, Inc.
AgMedica Bioscience, Inc. Agricultural Commodities/MillingProcess Industries Part of Atlas Global Brands, Inc., AgMedica Bioscience, Inc. is a Canadian company that cultivates, produces, distributes, and sells cannabis-related products. The private company is based in Chatham-Kent, Canada. AgMedica Bioscience was acquired by Silver Phoenix Resources, Inc. on January 04, 2023 for $9.32 million. The company was founded by Peter van Mol. Trevor Henry has been the CEO of the company since 2016. | Process Industries |
Contract Pharmaceuticals Ltd.
Contract Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Contract Pharmaceuticals Ltd. is a contract development and manufacturing organization (CDMO) specializing in non-sterile liquid and semi-solid pharmaceutical products. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Canadian company has over 25 years of experience in the industry and has built its expertise in liquids and semi-solids. The company's product development team consists of 45 people, including more than 30 scientists, with decades of formulation development and analytical experience. The company was founded in 1991, and Jan Sahai has been the CEO of the company since 2005. | Health Technology |
- Bolsa de valores
- Insiders
- William Demers